gracecast-103_lung-cancer_immunotherapy: yervoy, anti-pd-1, reolysin, talactoferrin by dr. brahmer
Published 12 years ago • 580 plays • Length 23:37Download video MP4
Download video MP3
Similar videos
-
7:41
gracecast-113_lung-cancer_asco 2012 lc highlights: dr. neal on anti-pd-1 immunotherapy for nsclc
-
26:02
doctors discuss: immunotherapy in lung cancer
-
6:56
gracecast - leading treatment options for patients with negative tumor pd-l1 nsclc with dr. stephen
-
8:03
gracecast - immunotherapy for small cell lung cancer with dr. stephen liu
-
13:40
gracecast-104_lung-cancer_immunotherapy for lung cancer: q and a session
-
21:41
gracecast-102_lung-cancer_immunotherapy: mage-a3, stimuvax, and lucanix, by dr. r. govindan
-
11:05
gracecast - lcvl - can immunotherapy help patients with small cell lung cancer
-
11:12
the future of cancer immunotherapy: combination treatments
-
9:49
gracecast - treatment options for patients with nsclc and high tumor pd-l1 expression
-
4:09
immunotherapy combinations: is this the future for treating lung cancer?
-
11:36
immunotherapy for lung cancer: currently enrolling clinical trials of combination therapies
-
3:22
acquired resistance in lung cancer treatment - lcvl 2024
-
9:26
gracecast - lcvl - which patients with advanced nsclc are good candidates for first line immunothera
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
5:24
gracecast - lcvl - can immunotherapy help frail patients with advanced nsclc
-
9:18
gracecast - treatment options for metastatic nsclc
-
6:42
maintenance systemic therapy: the nrg-lu trial - onctalk lung 2023
-
3:47
gracecast - lcvl what is the role of immunotherapy for unresectable stage 3 nsclc today
-
2:13
lung cancer video library - immunotherapy in stage lll nsclc - the pacific trial and imfinzi